Zobrazeno 1 - 10
of 308
pro vyhledávání: '"Adrian P, Gee"'
Autor:
Ashraf El Fiky, Laarni Ibenana, Robert Anderson, Joshua M. Hare, Aisha Khan, Adrian P. Gee, Cliona Rooney, David H. McKenna, Joseph Gold, Linda Kelley, Martha S. Lundberg, Lisbeth A. Welniak, Robert Lindblad
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 6, Pp 2099-2110 (2021)
Abstract The Production Assistance for Cellular Therapies (PACT) Program, is funded and supported by the US Department of Health and Human Services’ National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI) to advance deve
Externí odkaz:
https://doaj.org/article/ff938c54c87c45968ca22d3530c8d620
Autor:
Ifigeneia Tzannou, Ayumi Watanabe, Swati Naik, Rachel Daum, Manik Kuvalekar, Kathryn S. Leung, Caridad Martinez, Ghadir Sasa, Mengfen Wu, Adrian P. Gee, Robert A. Krance, Stephen Gottschalk, Helen E. Heslop, Bilal Omer
Publikováno v:
Blood Advances, Vol 3, Iss 17, Pp 2571-2580 (2019)
Abstract: Cytomegalovirus (CMV) infections remain a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT), and standard antiviral therapies are associated with significant side effects and development
Externí odkaz:
https://doaj.org/article/c60a0ab90f4b4a43a83c0af8a30c6454
Autor:
Allistair A. Abraham, Tami D. John, Michael D. Keller, C. Russell N. Cruz, Baheyeldin Salem, Lauren Roesch, Hao Liu, Fahmida Hoq, Bambi J. Grilley, Adrian P. Gee, Hema Dave, David A. Jacobsohn, Robert A. Krance, Elizabeth. J. Shpall, Caridad A. Martinez, Patrick J. Hanley, Catherine M. Bollard
Publikováno v:
Blood Advances, Vol 3, Iss 14, Pp 2057-2068 (2019)
Abstract: Adoptive transfer of virus-specific T cells (VSTs) has been shown to be safe and effective in stem cell transplant recipients. However, the lack of virus-experienced T cells in donor cord blood (CB) has prevented the development of ex vivo
Externí odkaz:
https://doaj.org/article/c8185b6b4cdf45c295fb6e5a5bd795c2
Autor:
Roya Ramezankhani, Shukoofeh Torabi, Neda Minaei, Hoda Madani, Siamak Rezaeiani, Seyedeh Nafiseh Hassani, Adrian P. Gee, Massimo Dominici, Daniela Nascimento Silva, Hossein Baharvand, Ensiyeh Hajizadeh-Saffar
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
The introduction of advanced therapy medicinal products (ATMPs) to the global pharma market has been revolutionizing the pharmaceutical industry and has opened new routes for treating various types of cancers and incurable diseases. In the past two d
Externí odkaz:
https://doaj.org/article/033d25a8d5894a599155481a748edfd3
Autor:
Maria da Graça Cabreira, Xiaohong Wang, Andre Critsinelis, Mekedlawit Setegne, Parisa Lotfi, Ying-Wooi Wan, Gabriela Barrios, Zhuyong Mei, Adrian P. Gee, Louis Maximilian Buja, Emerson Perin
Publikováno v:
Cytotherapy. 24:1201-1210
Stem and progenitor cells of hematopoietic and mesenchymal lineages reside in the bone marrow under low oxygen (OUsing cell-based assays and transcriptome and proteome data, the authors compared MSC cultures simultaneously grown under a conventional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4127e82f9a9f95853fd6908ae7b4d33
https://doi.org/10.1016/j.jcyt.2022.06.005
https://doi.org/10.1016/j.jcyt.2022.06.005
Autor:
David H. M. Steffin, Ibrahim N. Muhsen, LaQuisa C. Hill, Carlos A. Ramos, Nabil Ahmed, Meenakshi Hegde, Tao Wang, Mengfen Wu, Stephen Gottschalk, Sarah B. Whittle, Premal D. Lulla, Maksim Mamonkin, Bilal Omer, Rayne H. Rouce, Andras Heczey, Leonid S. Metelitsa, Bambi J. Grilley, Catherine Robertson, Virginia Torrano, Natalia Lapteva, Adrian P. Gee, Cliona M. Rooney, Malcolm K. Brenner, Helen E. Heslop
Publikováno v:
Blood. 140:16-24
Subsequent malignancies are well-documented complications in long-term follow-up of cancer patients. Recently, genetically modified immune effector (IE) cells have shown benefit in hematologic malignancies and are being evaluated in clinical trials f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbcbd710cd0342ff21ad6200231b66fa
https://doi.org/10.1182/blood.2022015728
https://doi.org/10.1182/blood.2022015728
Autor:
Cliona M. Rooney, Malcolm K. Brenner, Helen E. Heslop, Carlos A. Ramos, Adrian P. Gee, Elizabeth Pacheco, April Durett, Aaron Orozco, Melissa Gates, Keli Sharpe, Conrad Russel Cruz, Gianpietro Dotti, Barbara Savoldo, Bilal Omer, Hao Liu, Rayne H. Rouce, Olga Dakhova, Darshana Raghavan, Manasa Hiregange, Tamara Tripic, Robert A. Krance, Swati Naik, Mina Al-Sabbagh, Lisa A. Rollins, Iulia Diaconu, Margaret Gilbert, Natalia Lapteva
Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e0f71fe82cdf65f01ec3b452c7b2622
https://doi.org/10.1158/1078-0432.22472346
https://doi.org/10.1158/1078-0432.22472346
Autor:
Cliona M. Rooney, Malcolm K. Brenner, Helen E. Heslop, Carlos A. Ramos, Adrian P. Gee, Elizabeth Pacheco, April Durett, Aaron Orozco, Melissa Gates, Keli Sharpe, Conrad Russel Cruz, Gianpietro Dotti, Barbara Savoldo, Bilal Omer, Hao Liu, Rayne H. Rouce, Olga Dakhova, Darshana Raghavan, Manasa Hiregange, Tamara Tripic, Robert A. Krance, Swati Naik, Mina Al-Sabbagh, Lisa A. Rollins, Iulia Diaconu, Margaret Gilbert, Natalia Lapteva
Purpose:Current protocols for CD19 chimeric antigen receptor–expressing T cells (CD19.CAR-T cells) require recipients to tolerate preinfusion cytoreductive chemotherapy, and the presence of sufficient target antigen on normal or malignant B cells.P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e8d2194bcd7d99c6b8cfe15c50c87f
https://doi.org/10.1158/1078-0432.c.6528198
https://doi.org/10.1158/1078-0432.c.6528198
Autor:
Robert Sinclair, Yitian Zeng, Gentaro Ikeda, Ji Hye Jung, Christine Wahlquist, Utkan Demirci, Yunshin Jung, Nathan Bayardo, Adrian P. Gee, Connor O'Brien, Zewen Jiang, Katrin J. Svensson, Elizabeth S. Egan, Evgeniya Vaskova, Michelle R. Santoso, Phillip C. Yang, Ronald M. Witteles, Mark Mercola, Mehmet Ozgun Ozen, Liye Shi
Publikováno v:
JACC: CardioOncology
Background Anthracycline-induced cardiomyopathy (AIC) is a significant source of morbidity and mortality in cancer survivors. The role of mesenchymal stem cells (MSCs) in treating AIC was evaluated in the SENECA trial, a Phase 1 National Heart, Lung,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41c25d014101ed00cc5bea7576b26705
https://doi.org/10.1016/j.jaccao.2021.05.006
https://doi.org/10.1016/j.jaccao.2021.05.006
Autor:
Laarni Ibenana, Ashraf El Fiky, David H. McKenna, Martha S. Lundberg, Joseph Gold, Lisbeth A. Welniak, Adrian P. Gee, Robert Lindblad, Linda Kelley, Aisha Khan, Joshua M. Hare, Cliona M. Rooney, Robert H. Anderson
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 6, Pp 2099-2110 (2021)
Clinical and Translational Science
Clinical and Translational Science
The Production Assistance for Cellular Therapies (PACT) Program, is funded and supported by the US Department of Health and Human Services’ National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI) to advance development o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79520ab43e84a7f7aef1b85241523ed9
https://doi.org/10.1111/cts.13102
https://doi.org/10.1111/cts.13102